Bristol Myers Squibb Co. stock falls Monday, underperforms market

Shares of Bristol Myers Squibb Co. BMY,
-0.98%
shed 0.98% to $ 76.75 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX,
-0.02%
falling 0.02% to 4,391.69 and Dow Jones Industrial Average DJIA,
-0.11%
falling 0.11% to 34,411.69. The stock’s fall snapped a three-day winning streak. Bristol Myers Squibb Co. closed $ 1.38 below its 52-week high ($ 78.13), which the company reached on April 11th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson JNJ,
-1.25%
fell 1.25% to $ 177.66, Merck & Co. Inc. MRK,
-0.97%
fell 0.97% to $ 86.07, and Pfizer Inc. PFE,
-2.41%
fell 2.41% to $ 51.84. Trading volume (10.6 M) remained 5.2 million below its 50-day average volume of 15.7 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Leave a Comment